Dupont Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Dupont Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,992	Closed	-$545K	–	1961
2021 Q2	$545K	Sell	7,992 -12,275	-61%	-$800K	0.01%	923
2021 Q1	$1.41M	Sell	20,267 -3,215	-14%	-$247K	0.03%	475
2020 Q4	$1.8M	Buy	23,482 +19,964	+567%	+$1.5M	0.04%	364
2020 Q3	$263K	Buy	3,518 +1,565	+80%	+$104K	0.01%	1026
2020 Q2	$123K	Buy	+1,953	New	+$107K	﹤0.01%	1232
2017 Q4	–	Sell	-16,568	Closed	-$422K	–	1011
2017 Q3	$422K	Buy	+16,568	New	+$380K	0.01%	711

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Dupont Capital Management's ARNA Position: Q3 2021 in Review

Dupont Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2021, closing a stake of 7,992 shares — an estimated $545K sold.

Dupont Capital Management first reported a position in ARNA in Q3 2017 and held it in 6 quarters. The position peaked at $1.8M in Q4 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

Dupont Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
Dupont Capital Management sold 7,992 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $545K.
Dupont Capital Management first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and held it in 6 quarters.
Dupont Capital Management's Arena Pharmaceuticals Inc position peaked at $1.8M in Q4 2020.
235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on Dupont Capital Management's 13F filing for Q3 2021, filed 3 Nov 2021.